What would you suggest in response to Ms. Little's point about the price that the drug company is asking for the treatment of her daughter's cystinosis? The system would seem to have failed if they're asking for $100,000 and there's nothing we can do about it.
If, for example, Vertex is not bringing the drug to market, does that not suggest to you that the present system is failing?